Dexamethasone/levofloxacin
Combination of | |
---|---|
Dexamethasone | Corticosteroid |
Levofloxacin | Anti-infective |
Clinical data | |
Trade names | Levodexa |
Routes of administration | Eye drops |
ATC code | |
Legal status | |
Legal status |
Dexamethasone/levofloxacin, sold under the brand name Levodexa, is a fixed-dose combination medication used for the prevention and treatment of inflammation, and the prevention of infection, associated with cataract surgery.[1] It contains dexamethasone, a corticosteroid; and levofloxacin, an anti-infective.[1]
It was approved for medical use in Canada in December 2023.[1]
Medical uses[edit]
Dexamethasone/levofloxacin is indicated for the prevention and treatment of inflammation, and the prevention of infection, associated with cataract surgery in adults.[1]
References[edit]
- ^ a b c d e "Regulatory Decision Summary for Levodexa". Drug and Health Products Portal. 12 December 2023. Retrieved 2 April 2024.
- ^ "Levodexa Product information". Health Canada. 12 December 2023. Retrieved 2 April 2024.